Lenalidomide is used to treat various types of cancer. It works by slowing down or stopping the growth of cancer cells. It can also be used to treat anemia of certain blood/bone marrow diseases (myelodysplastic syndrome-MDS). Lenalidomide can reduce the need for blood transfusions. Lenalidomide is not recommended to treat certain types of cancer (chronic lymphocytic leukemia) because it increases the risk of serious heart-related side effects and death. If you have this cancer, talk to your doctor about the risks of using this medicine.
How to use lenalidomide capsules
Please read the Medication Guide provided by your pharmacist before starting lenalidomide and every time you supplement. If you have any questions, please consult your doctor or pharmacist.
Follow your doctor's instructions to take this medication by mouth, with or without food, usually once a day. Swallow the whole medicine with water. For the treatment of certain diseases, you may be instructed to take the drug in cycles (once a day for 21 days, then stop the drug for 7 days). The dosage depends on your medical condition, response to treatment, and laboratory test results. Make sure to follow your doctor's instructions carefully.
Do not open, chew or break the capsule, and do not over-process the capsule. If any powder in the capsule gets on the skin, wash the area with soap and water.
Because the drug can be absorbed through the skin and lungs, and may harm an unborn baby, pregnant women or women who may become pregnant should not use the drug or inhale dust from broken capsules. Everyone should wash their hands thoroughly after using the drug.
Use this medication regularly to get the most benefit from it. Remember to take it at the same time each day.
Do not increase your dose or use this drug more often or for longer than prescribed. Your condition will not improve any faster, and your risk of side effects will increase.
Friday, February 19, 2021
Lenalidomide Capsule Uses
Saturday, February 13, 2021
BORTEZOMIB FOR INJECTION BORTENAT LYOPHILIZED USES AND SIDE EFFECTS
This medication is given by a healthcare professional by intravenous injection or under the skin. If you receive this medication under the skin, make sure to change the injection site every time to reduce the damage under the skin. The dosage depends on your size, medical condition, laboratory tests, and response to treatment.
To prevent dehydration, be sure to drink plenty of fluids when using this medication. If you have any questions, please consult your doctor or pharmacist.
Dizziness, dizziness, nausea, vomiting, loss of appetite, diarrhea, constipation, fatigue, weakness, or pain/redness at the injection site may occur. Nausea, vomiting and diarrhea can be severe. In some cases, your doctor may prescribe medication to prevent or relieve nausea, vomiting, and diarrhea. If these effects persist or worsen, please inform your doctor or pharmacist immediately.
To reduce the risk of dizziness and dizziness, get up slowly when lifting from a sitting or lying position.
People who use this drug may have serious side effects. However, your doctor prescribed this medicine because he or she judged that the benefits to you outweigh the risks of side effects. The doctor's careful monitoring may reduce your risk.
Bortezomib sometimes causes side effects due to the rapid destruction of cancer cells (tumor lysis syndrome). To reduce the risk, your doctor may add medicine and tell you to drink plenty of water. Tell your doctor immediately if you have the following symptoms: lower back/side pain (back pain), signs of kidney problems (such as painful urination, pink/bloody urine, changes in urine output), muscle cramps/weakness.
If you have any serious side effects, please tell your doctor immediately, including: tingling/numbness/pain/arm/leg fever, syncope, severe headache, mental/mood changes (such as confusion), severe abdominal/abdominal pain, signs of liver disease (Such as yellow eyes/skin, yellow urine), heart failure symptoms (such as shortness of breath, ankle/foot swelling, abnormal fatigue, abnormal weight/sudden increase).
If you have any very serious side effects, seek medical help immediately, including: chest pain, difficulty breathing, vision changes, seizures, weakness on one side of the body, and difficulty speaking.
This medication can reduce blood cells, which can lead to anemia, reduce the body's ability to fight infection or cause easy bruising/bleeding. Tell your doctor immediately if you experience any of the following symptoms: easy bleeding/bruising, black/tar-like stools, vomit that looks like coffee grounds, signs of infection (such as persistent sore throat, fever, chills), abnormal Tired, pale skin.
Very severe allergic reactions to this drug are rare. However, if you notice any symptoms of a severe allergic reaction, including skin rash, itching/swelling (especially face/tongue/throat), severe dizziness, and difficulty breathing, please seek medical help immediately.
Bortezomib usually causes a rash, which is usually not serious. However, you may not be able to tell it apart from the rare rash, which may be a sign of a serious reaction. If a rash occurs, seek medical help immediately.
Thursday, February 11, 2021
Melphalan Tablet Side Effects
There may be nausea, vomiting, diarrhea, lip/mouth sores and loss of appetite. Nausea and vomiting can be severe. In some cases, your doctor may prescribe medication to prevent or relieve nausea and vomiting. Eating a few small meals, not eating before treatment, or restricting the amount of activity may help reduce some effects. If these effects persist or worsen, please inform your doctor or pharmacist immediately.
Temporary hair loss may occur. After the treatment, the hair returned to normal growth.
People who use this drug may have serious side effects. However, your doctor prescribed this medicine because he or she judged that the benefits to you outweigh the risks of side effects. The doctor's careful monitoring may reduce your risk.
If you have any serious side effects, please tell your doctor immediately, such as: shortness of breath, menstruation stopped (in women), symptoms of liver disease (such as stomach/abdominal pain, yellow eyes/skin, dark urine).
Very severe allergic reactions to this drug are rare. However, if you notice any symptoms of a severe allergic reaction, such as rash, itching/swelling (especially face/tongue/throat), severe dizziness, and difficulty breathing, please seek medical help immediately.
This is not a complete list of possible side effects. If you notice other effects not listed above, please contact your doctor or pharmacist
MELPHALAN USES
This drug is used to treat certain types of cancer (for example, multiple myeloma, ovarian cancer). Melphalan belongs to a class of drugs called alkylating agents. It works by slowing down or stopping the growth of cancer cells.
How to use Melphalan tablet
Follow your doctor’s instructions to take this medication by mouth, usually once a day. Unless your doctor instructs otherwise, drink plenty of water to help prevent side effects.
The dosage and treatment plan depend on your medical condition and response to treatment. Take the medicine carefully as directed by your doctor.
Do not increase the dose or take this drug more than specified. Your condition will not get better soon, and the risk of serious side effects will increase.
It may take several months for you to benefit from this medicine.
Since this drug can be absorbed through the skin and lungs and may harm an unborn baby, women who are pregnant or who may become pregnant should not handle this medication or breathe the dust from the tablets.
Wednesday, September 16, 2020
DOSAGE AND ADMINISTRATION ORENCIA
Adult rheumatoid arthritis
For adult patients with RA, ORENCIA can be administered by intravenous infusion or subcutaneous injection.
ORENCIA can be used as a monotherapy or with DMARDs other than TNF antagonists.
IV regimen
Orerncia lyophilized powder should be diluted and used after dilution [see adult psoriatic arthritis], and intravenous infusion of 30 minutes according to the dose based on the weight range specified in Table 1. After the first intravenous administration, intravenous infusion should be given at 2 and 1. 4 weeks after the first infusion and every 4 weeks thereafter.
Subcutaneous dosing regimen
ORENCIA 125 mg in a prefilled syringe or in the ORENCIA ClickJect™ auto-injector should be injected subcutaneously once a week [see preparation and dosing instructions for intravenous infusion], and can be started with or without an intravenous dose . named patient program For patients starting treatment with an intravenous loading dose, ORENCIA should be started with a single intravenous infusion (according to the weight category listed in Table 1), and then the first 125 mg subcutaneous injection should be given within the same day of the intravenous infusion.
Patients transitioning from Orencia intravenous therapy to subcutaneous administration should be given the first subcutaneous dose instead of the next scheduled intravenous dose.
Juvenile idiopathic arthritis
For patients with juvenile idiopathic arthritis (JIA), ORENCIA can be administered by intravenous infusion (6 years and older) or subcutaneous injection (2 years and older). No intravenous administration was given to patients under 6 years of age.
ORENCIA can be used as a monotherapy or concurrently with methotrexate.
IV regimen
ORENCIA should be administered as a 30-minute intravenous infusion based on body weight. Pediatric patients:
People weighing less than 75 kg should be administered ORENCIA at a dose of 10 mg/kg [see Adult Psoriatic Arthritis] After the adult intravenous administration regimen (see Table 1), Orencia should be given a body weight of 75 kg or more, and the maximum dose should not exceed 1,000 mg.
After the initial administration, ORENCIA should be administered 2 and 4 weeks after the first infusion and every 4 weeks thereafter. named patient basis,The unused part of the sample bottle must be discarded immediately.
Subcutaneous dosing regimen
Orencia for subcutaneous injection should be started without an intravenous dose, and the dose based on the weight range specified in Table 2 should be used.
Tuesday, April 14, 2020
Choosing a Healthcare Provider for Your HIV Treatment
HIV infection, safer sex practices
If you are newly identified with HIV, then you are feeling most overwhelmed and may seek escape and lax on the subject in search of a remedy. named patient medicines These behaviors are understandable, but will also be disastrous for your health. Initial measures will help you understand what is going on in your frame, and will also allow your provider to assess whether you need life-saving medicinal drugs immediately. It can prevent or delay the development of your disease for AIDS and protect you from getting sick. You also want an area to show for emotional support, records, and schooling. In the initial measure, you will get the facts about preventing HIV infection, more safe sex practices, and needle replacement programs if you are an intravenous drug user. You may also be directed to a counselor or your neighborhood health department to talk about notification of any sexual or needle-sharing peers in HIV-sensitive promotion.
If you are relocating to a new city, you want to research the health care options you have relocated to, and make great selections to continue your care well-timed.
As time goes on, you additionally want to trade carriers. It is constantly appropriate for you to stop looking at a company for any purpose and change it to another at any time. If you do not like your company, otherwise you feel uncomfortable with her or him, or if you feel that your health care wishes are not being addressed or that your thoughts about your treatment are really Different from your issuer, then it is time for you to look all the time. Other issuers.
The following are some important things to keep in mind while selecting the issuer:
Training and experience: HIV treatment is very complex and rapidly modifies, and many things have to be taken into account in any respect range of the disorder. HIV It is important that you become an HIV specialist (someone who treats a large number of HIV-afflicted victims and who is a consultant through the American Academy of HIV Medicine (http://www.Aahivm.Org/) Licensed in. Your issuer is. Dedicated to staying contemporary and up-to-date with the region. Ask how many HIV victims the company has treated, and currently, they Let's look at the numbers. Ask if he has experience in treating patients at all levels of the disease.
Possible problems related to HIV
Ask the workers' office body how long it usually takes to get an appointment or reschedule the appointment if you have to cancel. If you are sick or have any problems, inquire about being able to get an appointment soon. You may see a popular trainee for other primary care desires, pharmaceutical consulting companies but who is additionally willing to provide the number one care. Whenever another issuer treats you, the potential trouble related to HIV goes unnoticed or can be prescribed for a medicinal drug that has interactions with your HIV medications. You also want to know that when your smartphone is returned to your company, you have such questions, when you have such questions,
Email- alleviareindia@gmail.com
Contact - 9810421609
More Detail - http://www.alleviareindia.com/